Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis

• Published in: Journal of nanobiotechnology Vol. 22; no. 1; pp. 555 - 18
• Main Authors: Wu, Jiangyi, Wu, Jinhui, Xiang, Wei, Gong, Yunquan, Feng, Daibo, Fang, Shunzheng, Wu, Yaran, Liu, Zheng, Li, Yang, Chen, Ran, Zhang, Xiaoqi, Li, Bingfei, Chen, Lifeng, Jin, Runze, Li, Song, Zhang, Bin, Zhang, Tongyi, Yin, Lin, Zhou, Yizhao, Huang, Shu, Liu, Ningning, Xu, Hao, Lian, Jiqin, Wang, Yongqian, Zhou, Siru, Ni, Zhenhong
• Format: Journal Article
• Language: English
• Published: England BioMed Central 11.09.2024; BMC
• Subjects: Adipose Tissue - cytology; Animals; Cartilage, Articular - metabolism; Cells, Cultured; Chondrocytes; Disease Models, Animal; Exosomes; Exosomes - metabolism; Humans; Male; Mesenchymal Stem Cell Transplantation - methods; Mesenchymal stem cells; Mesenchymal Stem Cells - metabolism; Mice; Mice, Inbred C57BL; Osteoarthritis; Osteoarthritis - metabolism; Osteoarthritis - therapy; TNF-α precondition; Tumor Necrosis Factor-alpha - metabolism; Exosomes; TNF-α precondition; Osteoarthritis; Chondrocytes; Mesenchymal stem cells
• ISSN: 1477-3155; 1477-3155
• DOI: 10.1186/s12951-024-02795-9

The pathogenesis of osteoarthritis (OA) involves the progressive degradation of articular cartilage. Exosomes derived from mesenchymal stem cells (MSC-EXOs) have been shown to mitigate joint pathological injury by attenuating cartilage destruction. Optimization the yield and therapeutic efficacy of exosomes derived from MSCs is crucial for promoting their clinical translation. The preconditioning of MSCs enhances the therapeutic potential of engineered exosomes, offering promising prospects for application by enabling controlled and quantifiable external stimulation. This study aims to address these issues by employing pro-inflammatory preconditioning of MSCs to enhance exosome production and augment their therapeutic efficacy for OA. The exosomes were isolated from the supernatant of infrapatellar fat pad (IPFP)-MSCs preconditioned with a pro-inflammatory factor, TNF-α, and their production was subsequently quantified. The exosome secretion-related pathways in IPFP-MSCs were evaluated through high-throughput transcriptome sequencing analysis, q-PCR and western blot analysis before and after TNF-α preconditioning. Furthermore, exosomes derived from TNF-α preconditioned IPFP-MSCs (IPFP-MSC-EXOs ) were administered intra-articularly in an OA mouse model, and subsequent evaluations were conducted to assess joint pathology and gait alterations. The expression of proteins involved in the maintenance of cartilage homeostasis within the exosomes was determined through proteomic analysis. The preconditioning with TNF-α significantly enhanced the exosome secretion of IPFP-MSCs compared to unpreconditioned MSCs. The potential mechanism involved the activation of the PI3K/AKT signaling pathway in IPFP-MSCs by TNF-α precondition, leading to an up-regulation of autophagy-related protein 16 like 1(ATG16L1) levels, which subsequently facilitated exosome secretion. The intra-articular administration of IPFP-MSC-EXOs demonstrated superior efficacy in ameliorating pathological changes in the joints of OA mice. The preconditioning of TNF-α enhanced the up-regulation of low-density lipoprotein receptor-related protein 1 (LRP1) levels in IPFP-MSC-EXOs , thereby exerting chondroprotective effects. TNF-α preconditioning constitutes an effective and promising method for optimizing the therapeutic effects of IPFP-MSCs derived exosomes in the treatment of OA.